| Literature DB >> 30654238 |
Vitthal B Makane1, Vagolu Siva Krishna2, E Vamshi Krishna3, Manjulika Shukla4, B Mahizhaveni5, Sunil Misra3, Sidharth Chopra4, Dharmarajan Sriram2, V N Azger Dusthackeer5, Haridas B Rode6.
Abstract
The development of an effective antitubercular agent is a challenge due to the complex nature of tuberculosis. Herein, we report the synthesis and evaluation of α-aminoacyl amides as antitubercular agents. The systematic medicinal chemistry approach led to identification of optimal substitutions required for the activity. Compound 11l was identified as antitubercular lead with drug like properties. Further, 11l selectively inhibited M. tuberculosis H37Rv with MIC value of 0.78 μM and was found to be non-toxic to CHOK1 cells. The lead compound inhibited multidrug resistant and Pre-Extensively drug resistant strains of Mycobacterium at 2 μg/mL and 8 μg/mL respectively.Entities:
Keywords: Antitubercular agents; Drug-resistant tuberculosis; Heterocyclic compounds; Ugi reaction
Mesh:
Substances:
Year: 2019 PMID: 30654238 DOI: 10.1016/j.ejmech.2019.01.002
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514